TY  - JOUR

T1  - Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

JO  - The Lancet

PY  - 2022/09/15

AU  - Paller AS

AU  - Simpson EL

AU  - Siegfried EC

AU  - Cork MJ

AU  - Wollenberg A

AU  - Arkwright PD

AU  - Soong W

AU  - Gonzalez ME

AU  - Schneider LC

AU  - Sidbury R

AU  - Lockshin B et al

ED  - 

DO  - DOI: 10.1016/s0140-6736(22)01539-2

PB  - Elsevier BV

VL  - 400

IS  - 10356

SP  - 908

EP  - 919

Y2  - 2024/12/22

ER  -